2019
DOI: 10.1542/peds.2018-3341
|View full text |Cite
|
Sign up to set email alerts
|

Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis

Abstract: BACKGROUND: Coronary artery aneurysms (CAA) are a serious complication of Kawasaki disease. Treatment with intravenous immunoglobulin (IVIg) within 10 days of fever onset reduces the risk of CAA from 25% to ,5%. Corticosteroids and infliximab are often used in high-risk patients or those with CAA at diagnosis, but there are no data on their longer-term impact on CAA.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
32
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
8
1
1

Relationship

2
8

Authors

Journals

citations
Cited by 64 publications
(39 citation statements)
references
References 28 publications
2
32
0
Order By: Relevance
“…The regimen included initial treatment with IVIG and aspirin, with the addition of corticosteroid therapy for those with shock or at greater risk of coronary artery aneurysm. 12 Biological modifying medication was also given to those who were unresponsive to IVIG and corticosteroids. 13 This treatment protocol was associated with rapid clinical improvement and reduction in inflammatory markers in most patients, with no mortality.…”
Section: Discussionmentioning
confidence: 99%
“…The regimen included initial treatment with IVIG and aspirin, with the addition of corticosteroid therapy for those with shock or at greater risk of coronary artery aneurysm. 12 Biological modifying medication was also given to those who were unresponsive to IVIG and corticosteroids. 13 This treatment protocol was associated with rapid clinical improvement and reduction in inflammatory markers in most patients, with no mortality.…”
Section: Discussionmentioning
confidence: 99%
“…Son et al developed the risk scores for predicting coronary artery aneurysms in a north American population and validated the score including baseline Z score ≥ 2.0, age < 6 months, Asian race, and C-reactive protein (CRP) ≥ 13 mg/dL [24]. Dionne et al recently showed that adjunctive corticosteroid therapy with IVIG may be protective against progression of coronary artery aneurysms based on Son's score [25]. Tremoulet et al developed a scoring system for predicting coronary artery aneurysms: illness days ≤ 4 days, 1 point; bands ≥ 20%, 2 points; γglutamyl transpeptidase ≥ 60 U/L, 1 point; age-adjusted hemoglobin concentrations ≤ − 2, 1 point [26].…”
Section: Introductionmentioning
confidence: 99%
“…Although the uncommon presentation of KD in this newborn may have prompted clinicians to consider other medium vessel vasculitides such as polyarteritis nodosa, the efficacy of IVIG and favorable prognosis led us to believe that KD was the most appropriate diagnosis for this patient. In terms of initial therapy, corticosteroids are often used in addition to IVIG in high-risk patients or those with CAAs at diagnosis, and they have been proven to have a favorable long-term effect on CAAs [17]. Considering the early age of onset and multiple aneurysms in this patient, anticoagulation with LMWH or warfarin was added to aspirin for more aggressive prophylaxis of thrombosis, which is also a class IIb recommendation of the 2017 AHA guidelines for medium CAAs [12].…”
Section: Discussionmentioning
confidence: 99%